Answers are grounded in this paper and cite their sources.
In this edition of Blood, Bertaina et al report 3-year survival exceeding 90% by using haploidentical αβ+CD3+/CD19+-depleted allogeneic transplantation for children with nonmalignant disorders.
No takes yet. Share an insight, caveat, or question.
Michael A. Pulsipher (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: